Back to search

Boston University

Alternative therapies to tumor necrosis factor alpha for treatment of Crohn’s disease

Abstract

dc:description.abstract

Crohn’s Disease is an immune mediated condition characterized by relapsing and remitting inflammation of the gastrointestinal tract. Although exact etiology is unknown, current research shows pro-inflammatory cytokines tumor necrosis factor-alpha, interleukin-6, and interferon gamma are key players in the initiation of inflammation. Acute inflammation is treated with first line therapy of corticosteroids and thiopurines to induce remission. As these drugs are not recommended for long term use, monoclonal antibodies are recommended in the maintenance phase of remission. Crohn’s disease is progressive and destructive, and often requires surgical intervention following the ever-changing pharmaceutical regimens patients require. Alternative therapies to the first line of anti-tumor necrosis factor-alpha inhibitors target different pathways, though in this case as well, specific mechanisms of action remain elusive. Further research is warranted to study both minute pathways to inflammation as well as comparative, head-to-head studies in human subjects for alternative monoclonal antibody therapy.

Degree

thesis:*
Name thesis:degree_name
Master of Science
Level thesis:degree_level
masters
Discipline thesis:degree_discipline
Medical Sciences
Grantor
Boston University
Year dc:date.issued
2022

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Sargent, Bethany Margaret
Advisor dc:contributor.advisor
  • Remick, Daniel
ORCID dc:identifier.orcid

Subjects

dc:subject × 4

Rights

Language dc:language.iso
en_US

Identifiers

dc:identifier.*
Handle dc:identifier.uri
https://hdl.handle.net/2144/45699

Chain of custody

source
Harvested from
Boston University
Base URL
open.bu.edu/oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Sargent, Bethany Margaret. Alternative therapies to tumor necrosis factor alpha for treatment of Crohn’s disease. masters thesis, Boston University, 2022. https://hdl.handle.net/2144/45699